Welcome to our dedicated page for ABG Acquisition I SEC filings (Ticker: JABRU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ABG Acquisition I's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ABG Acquisition I's regulatory disclosures and financial reporting.
JAB Acquisition Corp I director Ingargiola Luisa has reported an initial holding of 35,000 Class A ordinary shares. The filing indicates these shares were issued as compensation for services rendered, rather than through open-market buying or selling. This is a routine Form 3 that establishes the director’s equity stake and does not disclose any separate purchase or sale transactions.
JAB Acquisition Corp I director and officer Jack Bressman reported his initial beneficial ownership on Form 3. The filing shows indirect ownership of 657,221 Class B ordinary shares through JAB Acquisition Sponsor I, LLC.
These Class B ordinary shares automatically convert into Class A ordinary shares on a one-for-one basis concurrently with or immediately following the company’s initial business combination, subject to adjustments and anti-dilution rights. The reported holdings exclude 86.66 private placement shares and warrants and 22 private right shares that are expected to be issued in a private placement.
JAB Acquisition Corp I director David Pfeffer reported beneficial ownership of 30,000 Class A ordinary shares. A footnote explains these shares were issued as compensation for services rendered, so this filing mainly records his initial equity position rather than a buy or sell transaction.
JAB Acquisition Corp I, a Cayman Islands blank check company, has filed to offer 15,000,000 units at $10.00 each in an initial public offering, targeting a $150 million raise. Each unit includes one Class A ordinary share, one redeemable warrant, and one right to receive one-fourth of a Class A share.
The company is a SPAC seeking an initial business combination of roughly $150–$200 million or more, with a focus on technology, healthcare and logistics, but with flexibility to pursue other sectors. IPO proceeds, plus $2.6 million from 260,000 private units purchased by the sponsor, will place $150,000,000 in a U.S. trust account, or $172,500,000 if the underwriters fully exercise their 2,250,000-unit over-allotment option.
Public shareholders may redeem their shares at the time of the business combination, while the sponsor’s 9,857,143 founder shares and anti-dilution rights mean sponsor ownership is structured to remain about 35% of ordinary shares after the deal, creating significant potential dilution to public investors. The SPAC has a 12‑month completion window, extendable twice by three months each with additional deposits to the trust account, and may also seek further extensions via shareholder-approved amendments.
JAB Acquisition Corp I is registering 15,000,000 units at $10.00 per unit in an initial public offering, plus 15,000,000 Class A ordinary shares issuable upon exercise of accompanying warrants. Each unit includes one Class A share, one redeemable warrant and one right to receive one‑fourth of a Class A share.
The SPAC will place $150,000,000 of IPO and private placement proceeds in a U.S. trust account to fund a future business combination, targeting sectors such as technology, healthcare and logistics. Public shareholders can redeem their shares at the time of the business combination or certain extensions, generally at cash equal to the trust balance per public share.
The company has a 12‑month completion window, extendable twice by three months each with additional per‑share deposits into the trust, and shareholders may further extend through amendments. The sponsor bought 9,857,143 founder Class B shares for $25,000 and 260,000 private units for $2.6 million, structured to own about 35% of ordinary shares at closing, which, together with private and representative shares, results in immediate and potentially material dilution and creates economic incentives and conflicts of interest around deal selection.